Illumina inc stock.

Shares of Illumina Inc. rallied 4.14% to $114.34 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...Get the latest Illumina, Inc. (ILMN) stock quote, charts, news, and other financial information to help you make more informed trading and investment decisions. See the company's financial performance, balance sheet, cash flow, earnings, and market outlook for the next year.Stock Price Forecast. According to 15 stock analysts, the average 12-month stock price forecast for Illumina stock is $200.33, which predicts an increase of 82.47%. The lowest target is $100 and the highest is $334. On average, analysts rate Illumina stock as …View Illumina, Inc ILMN investment & stock information. Get the latest Illumina, Inc ILMN detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Illumina Inc.’s stock growth can be attributed to the overall success of the stock market, with the S&P 500 Index and the Dow Jones Industrial Average experiencing positive movements. The company’s consecutive days of gains and increased trading volume also indicate growing investor interest.

Aug 18, 2021 · The base stock consideration was subject to a collar, where the number of shares issued at closing varied in the event the 20-trading-day volume weighted average price of Illumina stock as of 10 trading days prior to closing is between $295 and $399 but was fixed at 11.3 million shares if such volume weighted average share price is above $399 ... On this news, the Company’s stock price fell $7.42, or 5.6%, to close at $124.45 per share on October 18, 2023. What Now: Similarly situated shareholders may be eligible to participate in the class action against Illumina, Inc. Shareholders who want to act as lead plaintiff for the class should contact Robbins LLP. Plaintiffs must file their ...

The fund owned 3,831 shares of the life sciences company’s stock after selling 395 shares during the period. Bryn Mawr Capital Management LLC’s holdings in Illumina were worth $718,000 at the ...Illumina Inc Stock Forecast: Analysts Predict 15.52% Increase, Consensus to Buy. On May 18, 2023, Illumina Inc (ILMN) stock closed at $201.26. The 18 analysts offering 12-month price forecasts for ILMN have a median target of $232.50, with a high estimate of $334.00 and a low estimate of $150.00. The median estimate represents a …

Date. Title. Nov 14, 2023. Illumina To Webcast Upcoming Investor Conferences. Nov 13, 2023. Illumina launches Global Health Access Initiative to support acceleration of pathogen sequencing in low- and middle-income countries. Nov 9, 2023. Illumina Reports Financial Results for Third Quarter of Fiscal Year 2023. Nov 1, 2023.General Inquiries. Salli Schwartz, Vice President lllumina Investor Relations 5200 Illumina Way San Diego, CA 92122. 858.291.6421 [email protected] 25, 2023 · SAN DIEGO, April 25, 2023 /PRNewswire/ -- Illumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today announced its financial results for the first quarter of fiscal year 2023, which include the consolidated financial results for GRAIL. NEW YORK, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Illumina, Inc. ("Illumina" or the "Company") . Such investors are advised to contact ...The base stock consideration was subject to a collar, where the number of shares issued at closing varied in the event the 20-trading-day volume weighted average price of Illumina stock as of 10 trading days prior to closing is between $295 and $399 but was fixed at 11.3 million shares if such volume weighted average share price is above $399 ...

See Illumina, Inc. (ILMN) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.

Illumina is the market leader in the DNA sequencing industry. See why I think ILMN stock is highly overvalued at today's prices.

General Inquiries. Salli Schwartz, Vice President lllumina Investor Relations 5200 Illumina Way San Diego, CA 92122. 858.291.6421 [email protected] 7, 2013 · SAN DIEGO--(BUSINESS WIRE)--Jan. 7, 2013-- Illumina, Inc. (NASDAQ:ILMN) today announced that it has signed a definitive agreement to acquire Verinata Health, Inc., a leading provider of non-invasive tests for the early identification of fetal chromosomal abnormalities, for consideration of $350 million plus up to $100 million in milestone ... Illumina, Inc. ( NASDAQ:ILMN – Get Free Report) was the target of a large decline in short interest in October. As of October 31st, there was short interest totalling 5,180,000 shares, a decline of 5.6% from the October 15th total of 5,490,000 shares. Based on an average daily trading volume, of 1,690,000 shares, the short-interest ratio is ...Nov 30, 2023 · Illumina Inc.’s stock growth can be attributed to the overall success of the stock market, with the S&P 500 Index and the Dow Jones Industrial Average experiencing positive movements. The company’s consecutive days of gains and increased trading volume also indicate growing investor interest. NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Find the latest Illumina, Inc. (ILMN) stock quote, history, news and other vital information to help you with your stock …Illumina responds to European Commission's divestiture order. SAN DIEGO, Oct. 13, 2023 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN), has received an order from the European Commission (EC) directing the company to divest GRAIL. Receipt of the order is an important next step in evaluating divestiture options for GRAIL.Illumina faces a record fine from the EU as early as next week after the world’s biggest gene sequencing company bought Silicon Valley cancer screening start-up Grail for $8bn without Brussels ...

Discover historical prices for ILMN stock on Yahoo Finance. View daily, weekly or monthly format back to when Illumina, Inc. stock was issued. ... Illumina, Inc. (ILMN) NasdaqGS - NasdaqGS Real ...Interested parties may access the live teleconference through the Investor Info section of Illumina's website at investor.illumina.com. Alternatively, individuals can access the call by dialing 866.400.0049 or +1.323.794.2149 outside North America, both with Conference ID 1991305.As of June 30, 2023, Illumina's financial statement reveals some key figures. The company's long-term debt stands at $1.49 billion, while its current debt Best stocks to buy nowGeneral Inquiries. Salli Schwartz, Vice President lllumina Investor Relations 5200 Illumina Way San Diego, CA 92122. 858.291.6421 [email protected], Revvity Inc stock has a Growth Score of 90, Momentum Score of 36 and Quality Score of 68. Illumina, Inc. stock has a Growth Score of 90, Momentum Score of 17 and Quality Score of 49. Comparing Revvity Inc, Illumina and Inc.’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not.The investigation concerns whether Illumina and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] In 2015, Illumina formed GRAIL, Inc. ("GRAIL") as a corporate subsidiary to develop a blood-based cancer detection test.

Interactive Chart for Illumina, Inc. (ILMN), analyze all the data with a huge range of indicators.

Illumina, Inc. - Stock Information Stock Information Stock Quote NASDAQ: ILMN Price 101.95 Change + 0.38 Volume 3,331,867 % Change + 0.37% Intraday High …Stock Price Statistics. The stock price has decreased by -51.30% in the last 52 weeks. The beta is 1.16, so Illumina's price volatility has been higher than the market average.Detailed Financial Results for Illumina. Our earnings reports, supplementary data, 10Q and 10K, and selected other documents are available below by quarter. Please reach out to our Investor Relations …SAN DIEGO, March 2, 2023 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, and Myriad Genetics Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the expansion of a strategic partnership to broaden access to and availability of oncology homologous ...Stock Price Forecast. According to 15 stock analysts, the average 12-month stock price forecast for Illumina stock is $200.33, which predicts an increase of 82.47%. The lowest target is $100 and the highest is $334. On average, analysts rate Illumina stock as …164.88M. 214.60%. Get the latest Illumina, Inc. (ILMN) real-time quote, historical performance, charts, and other financial information to help you make more informed …ILMN Earnings Date and Information. Illumina last released its quarterly earnings results on November 9th, 2023. The life sciences company reported $0.33 EPS for the quarter, beating analysts' consensus estimates of $0.13 by $0.20. The company earned $1.12 billion during the quarter, compared to analysts' expectations of $1.13 billion.

... Illumina, Inc. and Encourages Investors to Contact the Firm. Globe Newswire (Thu, 30-Nov 9:00 PM ET). ILMN Investors Have Opportunity to Lead Illumina, Inc ...

Illumina said on Friday it would divest cancer test maker Grail in 12 months, according to the terms of the European Commission's order, if the life sciences company does not win its challenge in ...

Sep 21, 2020 · GRAIL stockholders excluding Illumina will receive approximately 9.9 million Illumina shares if the 20-trading-day volume weighted average price of Illumina stock as of 10 trading days prior to closing is above $399 and approximately 13.4 million Illumina shares if the 20-trading-day volume weighted average price of Illumina stock as of 10 ... On average, Wall Street analysts predict. that Illumina's share price could reach $173.60 by Nov 13, 2024. The average Illumina stock price prediction forecasts a potential upside of 58.12% from the current ILMN share price of $109.79.Find the latest Illumina, Inc. (ILMN) stock quote, history, news and other vital information to help you with your stock trading and investing.Jan 13, 2023 · This 38% fall for ILMN stock since late 2019 can primarily be attributed to 1. the company’s P/S ratio falling 50% to 6.8x trailing revenues now, vs. 13.7x in 2019, 2. a 7.2% rise in its average ... On average, Wall Street analysts predict. that Illumina's share price could reach $173.60 by Nov 13, 2024. The average Illumina stock price prediction forecasts a potential upside of 58.12% from the current ILMN share price of $109.79.On average, Wall Street analysts predict. that Illumina's share price could reach $173.60 by Nov 13, 2024. The average Illumina stock price prediction forecasts a potential upside of 58.12% from the current ILMN share price of $109.79.See Illumina, Inc. (ILMN) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.Illumina To Webcast Upcoming Investor Conference. August 28, 2023. SAN DIEGO, Aug. 28, 2023 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference: Morgan Stanley 21st Annual Global Healthcare Conference on September 11, 2023. Fireside chat at 9:55am …Illumina's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was $28.30. Hence, Illumina's PS Ratio for today is 3.55. Good Sign: Illumina Inc stock PS Ratio (=3.6) is close to 10-year low of 3.33. The historical rank and industry rank for Illumina's PS Ratio or its related term are showing as below:Illumina, a leading company specializing in DNA sequencing and array-based technologies, has recently announced the appointment of Jacob Thaysen as its Best stocks to buy now ContactInteractive Chart for Illumina, Inc. (ILMN), analyze all the data with a huge range of indicators. Get the latest Illumina Inc. (ILMN) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.

The fund owned 3,831 shares of the life sciences company’s stock after selling 395 shares during the period. Bryn Mawr Capital Management LLC’s holdings in Illumina were worth $718,000 at the ...Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics. Illumina Korea Hi Investment & Securities building 66 Yeoidaero Yeoungdeungpo-gu Seoul Korea 07325 Detailed Financial Results for Illumina. Our earnings reports, supplementary data, 10Q and 10K, and selected other documents are available below by quarter. Please reach out to our Investor Relations team at [email protected] if you have questions. Instagram:https://instagram. oilnewsvalue of 1964 nickele8 prop firmfidelity day trader Oct 5, 2023 · Interested parties may access the live teleconference through the Investor Info section of Illumina's website at investor.illumina.com. Alternatively, individuals can access the call by dialing 866.400.0049 or +1.323.794.2149 outside North America, both with Conference ID 1991305. This 38% fall for ILMN stock since late 2019 can primarily be attributed to 1. the company’s P/S ratio falling 50% to 6.8x trailing revenues now, vs. 13.7x in 2019, 2. a 7.2% rise in its average ... mortgages for healthcare workersbonds quotes Discover historical prices for ILMN stock on Yahoo Finance. View daily, weekly or monthly format back to when Illumina, Inc. stock was issued. ... Illumina, Inc. (ILMN) NasdaqGS - NasdaqGS Real ... nlst robinhood U.S. genetic testing company Illumina was fined a record 432-million-euro ($476 million) by the EU on Wednesday for closing its takeover of cancer test maker Grail before securing EU antitrust ...Get the latest Illumina, Inc. (ILU) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.